Timothy Marlowe
Has grant
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Timothy Marlowe serves as the Chief Scientific Officer at FAKNOSTICS, LLC in the United States. His research focuses on the role of PTK2 in idiopathic pulmonary fibrosis prognosis, the discovery of chemical probes targeting HER2-FAK cancer signaling, and the development of high-throughput assays to detect inhibitors of the FAK-Paxillin interaction. His work integrates computational methods with experimental biology to advance therapeutic strategies.
Recent Grants
Grant: Close
Discovery of PPI inhibitors for the FAK FAT domain
Open Date: 2022-12-09
Close Date: 2024-11-30
Grant: Close
Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis
Open Date: 2022-08-10
Close Date: 2024-07-31
Grant: Close
Discovery of Novel Peptidic Inhibitors of the Non-Catalytic Function of Focal Adhesion Kinase (FAK)
Open Date: 2019-09-01
Close Date: 2021-07-31
Grant: Close
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
Open Date: 2019-08-01
Close Date: 2025-07-31
Grant: Close
Focal Adhesion Kinase - Tumor Biology and Therapeutics
Open Date: 1996-09-30
Close Date: 2021-08-31
Articles (3)
Year:
2023
Year:
2020
Year:
2020
Collaborators (1)
Stephen M. Black
Professor & Chair
Florida International University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.